Arcadia Biosciences, Inc. (RKDA)Consumer Defensive | Packaged Foods | Dallas, United States | NasdaqCM
0.62 USD
-0.06
(-8.804%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 0.63 +0.00 (0.768%) ⇧ (July 13, 2026, 6:50 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:11 a.m. EDT
The immediate outlook is severely clouded by a massive 44.5% intraday spike followed by a sharp retracement, leaving the stock trading significantly below its 50-day moving average. This volatility, coupled with a statistical forecast predicting a further 13.6% decline over the next month, suggests a high-risk environment where momentum is currently turning against the asset. Fundamentally, the business is in distress with negative operating margins, shrinking revenue, and a catastrophic nine-year price trajectory that has erased 99.75% of shareholder value. While the company recently raised capital via a private placement, the lack of a dividend and the persistent losses indicate that the core operations are failing to generate sustainable cash flow. The combination of deteriorating fundamentals and weak short-term technicals makes this a speculative trap rather than an investment opportunity. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.145436 |
| AutoETS | 0.159757 |
| MSTL | 0.167520 |
| AutoTheta | 0.186347 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 3.51 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.080 |
| Excess Kurtosis | 0.34 |
| Attribute | Value |
|---|---|
| Sector | Consumer Defensive |
| Revenue per Share | 3.075 |
| Market Cap | 1,362,699 |
| Forward P/E | -0.49 |
| Beta | 0.54 |
| Profit Margins | -195.94% |
| Website | https://arcadiabio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8557895 |
| Address1 | 5,956 Sherry Lane |
| Address2 | Suite 2000 |
| All Time High | 7,040.0 |
| All Time Low | 0.63 |
| Ask | 0.7906 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 117,350 |
| Average Daily Volume3 Month | 3,141,636 |
| Average Volume | 3,141,636 |
| Average Volume10Days | 117,350 |
| Beta | 0.541 |
| Bid | 0.476 |
| Bid Size | 2 |
| Book Value | 1.403 |
| City | Dallas |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.6246 |
| Current Ratio | 3.787 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.6872 |
| Day Low | 0.6 |
| Display Name | Arcadia Biosciences |
| Dividend Date | 1,516,752,000 |
| Earnings Call Timestamp End | 1,746,727,200 |
| Earnings Call Timestamp Start | 1,746,727,200 |
| Earnings Timestamp End | 1,773,954,000 |
| Earnings Timestamp Start | 1,773,954,000 |
| Ebitda | -4,782,000 |
| Ebitda Margins | -1.0050399 |
| Enterprise To Ebitda | 0.509 |
| Enterprise To Revenue | -0.512 |
| Enterprise Value | -2,435,270 |
| Eps Forward | -1.28 |
| Eps Trailing Twelve Months | -5.72 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 530 756 7027 |
| Fifty Day Average | 0.91258 |
| Fifty Day Average Change | -0.28798002 |
| Fifty Day Average Change Percent | -0.31556687 |
| Fifty Two Week Change Percent | -85.57895 |
| Fifty Two Week High | 6.71 |
| Fifty Two Week High Change | -6.0854 |
| Fifty Two Week High Change Percent | -0.90691507 |
| Fifty Two Week Low | 0.6 |
| Fifty Two Week Low Change | 0.02459997 |
| Fifty Two Week Low Change Percent | 0.04099995 |
| Fifty Two Week Range | 0.6 - 6.71 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,431,696,600,000 |
| Float Shares | 1,771,718 |
| Forward Eps | -1.28 |
| Forward P E | -0.48796874 |
| Free Cashflow | 1,293,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 8 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.34320998 |
| Gross Profits | 1,633,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00162 |
| Held Percent Institutions | 0.16014 |
| Implied Shares Outstanding | 2,181,715 |
| Industry | Packaged Foods |
| Industry Disp | Packaged Foods |
| Industry Key | packaged-foods |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,677,628,800 |
| Last Split Factor | 1:40 |
| Long Business Summary | Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. |
| Long Name | Arcadia Biosciences, Inc. |
| Market | us_market |
| Market Cap | 1,362,699 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_10128457 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -9,323,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,494,256 |
| Open | 0.6611 |
| Operating Cashflow | -4,250,000 |
| Operating Margins | -0.70818 |
| Payout Ratio | 0.0 |
| Phone | 214 974 8921 |
| Post Market Change | 0.0048000216 |
| Post Market Change Percent | 0.7684953 |
| Post Market Price | 0.6294 |
| Post Market Time | 1,783,983,034 |
| Previous Close | 0.6849 |
| Price Hint | 4 |
| Price To Book | 0.44518888 |
| Price To Sales Trailing12 Months | 0.28640163 |
| Profit Margins | -1.95944 |
| Quick Ratio | 3.037 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0603 |
| Regular Market Change Percent | -8.8042 |
| Regular Market Day High | 0.6872 |
| Regular Market Day Low | 0.6 |
| Regular Market Day Range | 0.6 - 0.6872 |
| Regular Market Open | 0.6611 |
| Regular Market Previous Close | 0.6849 |
| Regular Market Price | 0.6246 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 185,119 |
| Return On Assets | -0.32825002 |
| Return On Equity | -1.5815101 |
| Revenue Growth | -0.083 |
| Revenue Per Share | 3.075 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Consumer Defensive |
| Sector Disp | Consumer Defensive |
| Sector Key | consumer-defensive |
| Shares Outstanding | 2,181,715 |
| Shares Percent Shares Out | 0.0107 |
| Shares Short | 23,325 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 411,143 |
| Short Name | Arcadia Biosciences, Inc. |
| Short Percent Of Float | 0.0107 |
| Short Ratio | 0.0 |
| Source Interval | 15 |
| State | TX |
| Symbol | RKDA |
| Total Cash | 3,720,000 |
| Total Cash Per Share | 1.809 |
| Total Debt | 0 |
| Total Revenue | 4,758,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -5.72 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.228365 |
| Two Hundred Day Average Change | -1.603765 |
| Two Hundred Day Average Change Percent | -0.7197048 |
| Type Disp | Equity |
| Volume | 185,119 |
| Website | https://arcadiabio.com |
| Zip | 75,225 |